Simplex Trading
RDY icon

Simplex Trading’s Dr. Reddy's Laboratories RDY Stock Holding History

Simplex Trading’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5K Sell
1,138
-43,638
-97% -$589K ﹤0.01% 7280
2026
Q1 		$620K Buy
+44,776
New +$623K ﹤0.01% 3025
2024
Q2 		– Sell
-3,375
Closed -$48.4K – 9625
2024
Q1 		$49K Buy
3,375
+2,035
+152% +$29.7K ﹤0.01% 6281
2023
Q4 		$18K Sell
1,340
-350
-21% -$4.68K ﹤0.01% 7014
2023
Q3 		$22K Buy
+1,690
New +$22.9K ﹤0.01% 6547
2022
Q4 		– Sell
-25
Closed – – 10200
2022
Q3 		$0 Buy
+25
New +$266 ﹤0.01% 10716
2020
Q4 		– Sell
-865
Closed -$11.6K – 8931
2020
Q3 		$12K Sell
865
-820
-49% -$9.77K ﹤0.01% 6713
2020
Q2 		$17K Buy
+1,685
New +$17.1K ﹤0.01% 6335
2019
Q2 		– Sell
-13,770
Closed -$108K – 7657
2019
Q1 		$111K Buy
13,770
+2,805
+26% +$21.3K ﹤0.01% 4233
2018
Q4 		$82K Buy
+10,965
New +$77.1K ﹤0.01% 4039
2018
Q3 		– Sell
-630
Closed -$4.21K – 7940
2018
Q2 		$4K Buy
+630
New +$3.97K ﹤0.01% 6815
2018
Q1 		– Sell
-30,860
Closed -$231K – 6735
2017
Q4 		$231K Sell
30,860
-2,375
-7% -$17.1K 0.01% 1172
2017
Q3 		$237K Buy
33,235
+31,515
+1,832% +$227K 0.01% 1081
2017
Q2 		$14K Buy
+1,720
New +$14K ﹤0.01% 3667
2017
Q1 		– Sell
-635
Closed -$5.48K – 6677
2016
Q4 		$5K Sell
635
-2,800
-82% -$26.1K ﹤0.01% 4380
2016
Q3 		$31K Buy
3,435
+3,155
+1,127% +$30.1K ﹤0.01% 2548
2016
Q2 		$2K Sell
280
-9,650
-97% -$88.4K ﹤0.01% 4990
2016
Q1 		$89K Sell
9,930
-2,595
-21% -$23.2K 0.01% 1455
2015
Q4 		$115K Sell
12,525
-1,000
-7% -$11K 0.01% 1245
2015
Q3 		$172K Buy
13,525
+7,915
+141% +$98.3K 0.01% 1013
2015
Q2 		$62K Buy
+5,610
New +$61.9K 0.01% 1533

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Simplex Trading's RDY Position: Q2 2026 in Review

Simplex Trading reduced its Dr. Reddy's Laboratories (RDY) stake by 97% in Q2 2026, selling an estimated $589K and leaving 1,138 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7280.

Simplex Trading first reported a position in RDY in Q2 2015 and has held it in 21 quarters since. The position peaked at $620K in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Simplex Trading held 1,138 shares of Dr. Reddy's Laboratories worth $16.5K as of Q2 2026.
  • Simplex Trading sold 43,638 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $589K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7280 holding.
  • Simplex Trading first reported a position in Dr. Reddy's Laboratories in Q2 2015 and has held it in 21 quarters since.
  • Simplex Trading's Dr. Reddy's Laboratories position peaked at $620K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.